Corvus Pharmaceuticals Ownership | Who Owns Corvus Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Corvus Pharmaceuticals Ownership Summary

Corvus Pharmaceuticals is owned by 56.27% institutional investors, 4.02% insiders, and 39.72% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.16% of CRVS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Corvus Pharmaceuticals shares.

CRVS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Corvus Pharmaceuticals	56.27%	4.02%	39.72%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Orbimed advisors	6.94M	14.16%	$12.64M
Samlyn capital	6.12M	12.49%	$11.14M
Point72 asset management	5.96M	12.16%	$10.86M
Adams street partners	3.28M	6.68%	$5.96M
Vanguard group	1.65M	3.37%	$3.00M
Renaissance	563.93K	1.15%	$1.03M
Blackrock	562.02K	1.15%	$1.02M
Geode capital management	460.14K	0.94%	$837.62K
Towerview	400.00K	0.82%	$728.00K
Morgan stanley	371.40K	0.76%	$675.95K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Adams street partners	3.28M	2.46%	$5.96M
Towerview	400.00K	0.48%	$728.00K
Orbimed advisors	6.94M	0.25%	$12.64M
Samlyn capital	6.12M	0.19%	$11.14M
Jackson square capital	63.77K	0.03%	$116.07K
Point72 asset management	5.96M	0.03%	$10.86M
Masso torrence wealth management	10.00K	0.01%	$18.20K
Hikari power	49.96K	0.01%	$91.00K
Bridgeway capital management	127.30K	0.01%	$231.69K
Quinn opportunity partners	22.33K	0.00%	$40.63K

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	5.96M	0.03%	5.96M
Samlyn capital	6.12M	0.19%	3.77M
Millennium management	204.60K	0.00%	181.32K
Vanguard group	1.65M	0.00%	157.14K
Morgan stanley	371.40K	0.00%	96.04K

Top Sellers

Holder	Shares	% Assets	Change
Bvf inc/il	-	-	-361.41K
Bridgeway capital management	127.30K	0.01%	-97.00K
Renaissance	563.93K	0.00%	-73.10K
Two sigma advisers, lp	113.40K	0.00%	-71.70K
Two sigma investments, lp	47.79K	0.00%	-54.66K

New Positions

Holder	Shares	% Assets	Change	Value
Point72 asset management	5.96M	0.03%	5.96M	$10.86M
Marshall wace, llp	74.56K	0.00%	74.56K	$135.70K
Cubist systematic strategies	24.36K	0.00%	24.36K	$44.34K
Royal bank of canada	7.24K	-	7.24K	$13.00K

Sold Out

Holder	Change
Ica group wealth management	-165.00
Wells fargo & company/mn	-265.00
Qube research	-2.38K
Group one trading	-4.60K
Fortem financial group	-11.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	50	-	27,591,708	54.15%	56	4.22%	19	-	10	-23.08%
Mar 31, 2024	50	-	17,899,766	-6.69%	36	2.38%	19	35.71%	13	18.18%
Dec 31, 2023	50	-10.71%	19,183,314	-0.02%	39	2.40%	14	-41.67%	11	-8.33%
Sep 30, 2023	56	-	19,186,336	-1.57%	40	2.30%	24	-31.43%	12	100.00%
Jun 30, 2023	56	51.35%	19,491,995	-6.26%	41	2.10%	35	250.00%	6	20.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.58M	2.53%	-
Vanguard Institutional Extnd Mkt Idx Tr	767.02K	1.23%	326.16K
Fidelity Extended Market Index	292.71K	0.47%	13.97K
Bridgeway Ultra-Small Company Market	123.70K	0.20%	-97.00K
BlackRock Extended Equity Market K	104.43K	0.17%	30.20K
iShares Micro-Cap ETF	95.96K	0.15%	-
Fidelity Total Market Index	91.31K	0.15%	10.95K
Fidelity Series Total Market Index	67.56K	0.11%	3.10K
NT Ext Equity Mkt Idx Fd - NL	50.56K	0.08%	22.46K
Northern Trust Extended Eq Market Idx	49.75K	0.08%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 06, 2024	Thompson Peter A.		Buy	$4.89M
May 06, 2024	Thompson Peter A.		Buy	$144.41
May 06, 2024	ORBIMED ADVISORS LLC		Buy	$144.41
May 06, 2024	ORBIMED ADVISORS LLC		Buy	$4.89M
May 06, 2024	Jones William Benton	See Remarks	Buy	$34.62K

Insider Transactions Trends

Date	Buy	Sell
2024 Q2	8	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q2	1	-
2023 Q1	-	-

CRVS Ownership FAQ

Who Owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals shareholders are primarily institutional investors at 56.27%, followed by 4.02% insiders and 39.71% retail investors. The average institutional ownership in Corvus Pharmaceuticals's industry, Biotech Stocks , is 45.43%, which Corvus Pharmaceuticals exceeds.

Who owns the most shares of Corvus Pharmaceuticals?

Corvus Pharmaceuticals’s largest shareholders are Orbimed advisors (6.94M shares, 14.16%), Samlyn capital (6.12M shares, 12.49%), and Point72 asset management (5.96M shares, 12.16%). Together, they hold 38.81% of Corvus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Corvus Pharmaceuticals?

Yes, BlackRock owns 1.15% of Corvus Pharmaceuticals, totaling 562.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.02M$. In the last quarter, BlackRock increased its holdings by 39.05K shares, a 7.47% change.

Who is Corvus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Adams street partners is Corvus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.46% of its assets in 3.28M Corvus Pharmaceuticals shares, valued at 5.96M$.

Who is the top mutual fund holder of Corvus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Corvus Pharmaceuticals shares, with 2.53% of its total shares outstanding invested in 1.58M Corvus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools